N-benzyl-6-oxo-5H-benzo[b][1,4]benzothiazepine-3-carboxamide

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并硫氮卓类
• 英文名称: N-benzyl-6-oxo-5H-benzo[b][1,4]benzothiazepine-3-carboxamide
• 化学式: C₂₁H₁₆N₂O₂S
• 分子量: 360.436
• InChiKey: GKSHIZCTKQGGKW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  26
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.05
• 拓扑面积：
  83.5
• 氢给体数：
  2
• 氢受体数：
  3

文献信息

• Hepatitis B core protein allosteric modulators
  申请人：Indiana University Research and Technology Corporation

  公开号：US10183936B2

  公开（公告）日：2019-01-22

  The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of treating viral infections, such as hepatitis B, comprising administering to a patient in need thereof a disclosed compound.

  本公开内容部分提供了对乙型肝炎病毒 Cp 具有异生效应特性的化合物。本文还提供了治疗病毒感染（如乙型肝炎）的方法，包括向有需要的患者施用所公开的化合物。
• SULFAMOYLBENZAMIDE DERIVATIVES AS ANTIVIRAL AGENTS AGAINST HBV INFECTION
  申请人：Baruch S. Blumberg Institute

  公开号：EP2726459B1

  公开（公告）日：2019-09-11
• HEPATITIS B CORE PROTEIN ALLOSTERIC MODULATORS
  申请人：INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY

  公开号：US20170015658A1

  公开（公告）日：2017-01-19

  The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of treating viral infections, such as hepatitis B, comprising administering to a patient in need thereof a disclosed compound.